New vaccine trains immune system to attack aggressive breast cancer

NCT ID NCT06324240

First seen Jan 27, 2026 · Last updated Apr 28, 2026 · Updated 13 times

Summary

This early-stage trial tests a personalized vaccine made from a patient's own tumor, combined with drugs that help the immune system attack cancer. The goal is to see if this approach is safe and can reduce the risk of triple-negative breast cancer returning. About 18 adults with various stages of this cancer will receive the vaccine alone or with checkpoint inhibitors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory Saint Joseph's Hospital

    RECRUITING

    Atlanta, Georgia, 30342, United States

    Contact Email: •••••@•••••

    Contact

  • Emory University Hospital Midtown

    RECRUITING

    Atlanta, Georgia, 30308, United States

    Contact Email: •••••@•••••

    Contact

  • Emory University Hospital/Winship Cancer Institute

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Email: •••••@•••••

    Contact

  • Grady Health System

    RECRUITING

    Atlanta, Georgia, 30303, United States

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

ANATOMIC STAGE I BREAST CANCER AJCC V8 ANATOMIC STAGE IA BREAST CANCER AJCC V8 ANATOMIC STAGE IA BREAST CANCER AJCC V8 ANATOMIC STAGE IB BREAST CANCER AJCC V8 ANATOMIC STAGE IB BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE II BREAST CANCER AJCC V8 ANATOMIC STAGE IIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIB BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 ANATOMIC STAGE III BREAST CANCER AJCC V8 ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 ANATOMIC STAGE IIIB BREAST CANCER AJCC V8 ANATOMIC STAGE IIIC BREAST CANCER AJCC V8 ANATOMIC STAGE IV BREAST CANCER AJCC V8 EARLY STAGE TRIPLE-NEGATIVE BREAST CARCINOMA LOCALLY ADVANCED TRIPLE-NEGATIVE BREAST CARCINOMA METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA PROGNOSTIC STAGE I BREAST CANCER AJCC V8 PROGNOSTIC STAGE IA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IB BREAST CANCER AJCC V8 PROGNOSTIC STAGE II BREAST CANCER AJCC V8 PROGNOSTIC STAGE II BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE III BREAST CANCER AJCC V8 PROGNOSTIC STAGE III BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIA BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIB BREAST CANCER AJCC V8 PROGNOSTIC STAGE IIIC BREAST CANCER AJCC V8 PROGNOSTIC STAGE IV BREAST CANCER AJCC V8 RECURRENT BREAST CARCINOMA UNRESECTABLE TRIPLE-NEGATIVE BREAST CARCINOMA